"Norpregnadienes" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Pregnadienes which have undergone ring contractions or are lacking carbon-18 or carbon-19.
Descriptor ID |
D009649
|
MeSH Number(s) |
D04.210.500.668.651.443
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Norpregnadienes".
Below are MeSH descriptors whose meaning is more specific than "Norpregnadienes".
This graph shows the total number of publications written about "Norpregnadienes" by people in this website by year, and whether "Norpregnadienes" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2018 | 3 | 0 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Norpregnadienes" by people in Profiles.
-
[Pharmacovigilance update]. Rev Med Suisse. 2021 Jan 13; 17(720-1):80-84.
-
Suspension of ulipristal acetate for uterine fibroids during ongoing EMA's review of liver injury risk: Unfortunate timing during the Covid-19 pandemic! Eur J Obstet Gynecol Reprod Biol. 2020 Sep; 252:300-302.
-
Absence of predictable long-term molecular effect of ulipristal acetate (UPA) on the endometrium. Reprod Biomed Online. 2019 May; 38(5):825-834.
-
Treatment continuation and satisfaction in women using combined oral contraception with nomegestrol acetate and oestradiol: a multicentre, prospective cohort study (BOLERO). Eur J Contracept Reprod Health Care. 2018 Dec; 23(6):393-399.
-
Failure of ulipristal acetate treatment as an indication for uterine malignancy: Two case reports. Medicine (Baltimore). 2018 Aug; 97(31):e11532.